Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.
Note: Council approval does not guarantee that a concept will become an initiative.
Table of Contents
Fiscal Year (FY) 2025 Concepts
- Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB)
- Halting Tuberculosis (TB) Transmission
- Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antibiotic-Resistant Gram-Negative Bacteria
- Promoting Innovative Research in Treponema pallidum Pathogenesis
- Notice of Special Interest (NOSI)—Research to Stimulate Diagnostic, Therapeutic, and Vaccine Development for Herpes Simplex Virus (HSV)
FY 2025 Small Business Innovation Research (SBIR) Contract Solicitation Topics
- Development of Medical Interventions for Treating Non-Tuberculosis Mycobacterial (NTM) Infections
- Development of Rapid Diagnostics for Mycoplasma genitalium Infection
- Diagnostics to Detect Host Immunity to Coccidioidomycosis (Valley Fever) or Histoplasmosis
- Software or Web Services to Automate Metadata Enrichment and Standardization for Data on Infectious and Immune-Mediated Diseases
- Software or Web Services to Assess Quality and Reproducibility of Data and Information About Therapeutics and Vaccines
Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB)
For the published request for applications, check the March 27, 2024 Guide announcement, Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (R01 Clinical Trial Not Allowed).
Halting Tuberculosis (TB) Transmission
For the published request for applications, check the July 17, 2024 Guide announcement, Halting Tuberculosis (TB) Transmission (R01, Clinical Trial Optional).
Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antibiotic-Resistant Gram-Negative Bacteria
For the published request for applications, check the April 1, 2024 Guide announcement, Partnerships for the Development of Tools to Advance Therapeutic Discovery Antibiotic-Resistant Gram-Negative Bacteria (R01 Clinical Trial Not Allowed).
Promoting Innovative Research in Treponema pallidum Pathogenesis
For the published request for applications, check the August 2, 2024 Guide announcement, Promoting Innovative Research in Treponema pallidum Pathogenesis (R21 Clinical Trial Not Allowed).
Notice of Special Interest (NOSI): Research to Stimulate Diagnostic, Therapeutic, and Vaccine Development for Herpes Simplex Virus (HSV)
For the published notice of special interest, check the March 27, 2024 Guide notice, Notice of Special Interest (NOSI): Research to Stimulate Development of Diagnostics, Therapeutics, and Vaccines for Herpes Simplex Virus (HSV).
Development of Medical Interventions for Treating Non-Tuberculosis Mycobacterial (NTM) Infections
For the published request for proposals, check the August 2, 2024 solicitation, A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals.
Development of Rapid Diagnostics for Mycoplasma genitalium Infection
For the published request for proposals, check the August 2, 2024 solicitation, A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals.
Diagnostics to Detect Host Immunity to Coccidioidomycosis (Valley Fever) or Histoplasmosis
For the published request for proposals, check the August 2, 2024 solicitation, A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals.
Software or Web Services to Automate Metadata Enrichment and Standardization for Data on Infectious and Immune-Mediated Diseases
Note: NIAID reissued topic proposed for NIH SBIR contract solicitation PHS 2025-1.
Request for Proposals
Contact:
Jonathan Bryan
jonathan.bryan@nih.gov
Software or Web Services to Assess Quality and Reproducibility of Data and Information About Therapeutics and Vaccines
For the published request for proposals, check the August 2, 2024 solicitation, A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals.